{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:33:05Z","timestamp":1788852785182,"version":"build-2803163510"},"reference-count":92,"publisher":"National Institute for Health and Care Research","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["10\/57\/32"],"award-info":[{"award-number":["10\/57\/32"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"Background<\/jats:title>Caesarean section is associated with blood loss and maternal morbidity. Excessive blood loss requires transfusion of donor (allogeneic) blood, which is a finite resource. Cell salvage returns blood lost during surgery to the mother. It may avoid the need for donor blood transfusion, but reliable evidence of its effects is lacking.<\/jats:p><\/jats:sec>Objectives<\/jats:title>To determine if routine use of cell salvage during caesarean section in mothers at risk of haemorrhage reduces the rates of blood transfusion and postpartum maternal morbidity, and is cost-effective, in comparison with standard practice without routine salvage use.<\/jats:p><\/jats:sec>Design<\/jats:title>Individually randomised controlled, multicentre trial with cost-effectiveness analysis. Treatment was not blinded.<\/jats:p><\/jats:sec>Setting<\/jats:title>A total of 26 UK obstetric units.<\/jats:p><\/jats:sec>Participants<\/jats:title>Out of 3054 women recruited between June 2013 and April 2016, we randomly assigned 3028 women at risk of haemorrhage to cell salvage or routine care. Randomisation was stratified using random permuted blocks of variable sizes. Of these, 1672 had emergency and 1356 had elective caesareans. We excluded women for whom cell salvage or donor blood transfusion was contraindicated.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Cell salvage (intervention) versus routine care without salvage (control). In the intervention group, salvage was set up in 95.6% of the women and, of these, 50.8% had salvaged blood returned. In the control group, 3.9% had salvage deployed.<\/jats:p><\/jats:sec>Main outcome measures<\/jats:title>Primary \u2013 donor blood transfusion. Secondary \u2013 units of donor blood transfused, time to mobilisation, length of hospitalisation, mean fall in haemoglobin, fetomaternal haemorrhage (FMH) measured by Kleihauer\u2013Betke test, and maternal fatigue. Analyses were adjusted for stratification factors and other factors that were believed to be prognostic a priori. Cost-effectiveness outcomes \u2013 costs of resources and service provision taking the UK NHS perspective.<\/jats:p><\/jats:sec>Results<\/jats:title>We analysed 1498 and 1492 participants in the intervention and control groups, respectively. Overall, the transfusion rate was 2.5% in the intervention group and 3.5% in the control group [adjusted odds ratio (OR) 0.65, 95% confidence interval (CI) 0.42 to 1.01;p<\/jats:italic>\u2009=\u20090.056]. In a planned subgroup analysis, the transfusion rate was 3.0% in the intervention group and 4.6% in the control group among emergency caesareans (adjusted OR 0.58, 95% CI 0.34 to 0.99), whereas it was 1.8% in the intervention group and 2.2% in the control group among elective caesareans (adjusted OR 0.83, 95% CI 0.38 to 1.83) (interactionp<\/jats:italic>\u2009=\u20090.46, suggesting that the difference in effect between subgroups was not statistically significant). Secondary outcomes did not differ between groups, except for FMH, which was higher under salvage in rhesus D (RhD)-negative women with RhD-positive babies (25.6% vs. 10.5%, adjusted OR 5.63, 95% CI 1.43 to 22.14;p<\/jats:italic>\u2009=\u20090.013). No case of amniotic fluid embolism was observed. The additional cost of routine cell salvage during caesarean was estimated, on average, at \u00a38110 per donor blood transfusion avoided.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>The modest evidence for an effect of routine use of cell salvage during caesarean section on rates of donor blood transfusion was associated with increased FMH, which emphasises the need for adherence to guidance on anti-D prophylaxis. We are unable to comment on long-term antibody sensitisation effects. Based on the findings of this trial, cell salvage is unlikely to be considered cost-effective.<\/jats:p><\/jats:sec>Future work<\/jats:title>Research into risk of alloimmunisation among women exposed to cell salvage is needed.<\/jats:p><\/jats:sec>Trial registration<\/jats:title>Current Controlled Trials ISRCTN66118656.<\/jats:p><\/jats:sec>Funding<\/jats:title>This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full inHealth Technology Assessment<\/jats:italic>; Vol. 22, No. 2. See the NIHR Journals Library website for further project information.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta22020","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T12:50:12Z","timestamp":1515588612000},"page":"1-88","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":40,"title":["A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial"],"prefix":"10.3310","volume":"22","clinical-trial-number":[{"clinical-trial-number":"isrctn66118656","registry":"10.18810\/isrctn","type":"results"}],"author":[{"given":"Khalid S","family":"Khan","sequence":"first","affiliation":[{"name":"Women\u2019s Health Research Unit, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Moore","sequence":"additional","affiliation":[{"name":"Selwyn Crawford Department of Anaesthetics, Birmingham Women\u2019s Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wilson","sequence":"additional","affiliation":[{"name":"School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hooper","sequence":"additional","affiliation":[{"name":"Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Allard","sequence":"additional","affiliation":[{"name":"Haematology, NHS Blood and Transplant, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Wrench","sequence":"additional","affiliation":[{"name":"Anaesthetics, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Roberts","sequence":"additional","affiliation":[{"name":"Health Economics Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"McLoughlin","sequence":"additional","affiliation":[{"name":"Health Economics Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Beresford","sequence":"additional","affiliation":[{"name":"Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Geoghegan","sequence":"additional","affiliation":[{"name":"Selwyn Crawford Department of Anaesthetics, Birmingham Women\u2019s Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Daniels","sequence":"additional","affiliation":[{"name":"Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Catling","sequence":"additional","affiliation":[{"name":"Department of Anaesthetics, Singleton Hospital, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki A","family":"Clark","sequence":"additional","affiliation":[{"name":"Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ayuk","sequence":"additional","affiliation":[{"name":"Women\u2019s Services, Royal Victoria Infirmary, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Robson","sequence":"additional","affiliation":[{"name":"Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Gao-Smith","sequence":"additional","affiliation":[{"name":"Perioperative, Critical Care and Trauma Trials Group, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hogg","sequence":"additional","affiliation":[{"name":"Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Jackson","sequence":"additional","affiliation":[{"name":"Health Economics Unit, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Lanz","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Unit, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dodds","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Unit, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2018,1]]},"reference":[{"key":"key2018010916181986_ref1-bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.2010.02847.x","article-title":"Saving mothers\u2019 lives: reviewing maternal deaths to make motherhood safer: 2006\u20132008","volume":"118","author":"Centre for Maternal and Child Enquiries","year":"2011","journal-title":"BJOG"},{"key":"key2018010916181986_ref1-bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/AOG.0b013e3181a81cdd","article-title":"Factors associated with peripartum hysterectomy","volume":"114","author":"Bodelon","year":"2009","journal-title":"Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib3","volume-title":"Female Admissions (Aged 16\u201350 Years) to Adult, General Critical Care Units in England, Wales and Northern Ireland Reported as \u2018Currently Pregnant\u2019 or \u2018Recently Pregnant\u2019","author":"Intensive Care National Audit & Research Centre","year":"2013"},{"key":"key2018010916181986_ref1-bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3109\/01443611003646298","article-title":"Indications and outcome for obstetric patients\u2019 admission to intensive care unit: a 7-year review","volume":"30","author":"Lataifeh","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"key2018010916181986_ref1-bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2044.2008.05581.x","article-title":"High dependency care in an obstetric setting in the UK","volume":"63","author":"Saravanakumar","year":"2008","journal-title":"Anaesthesia"},{"key":"key2018010916181986_ref1-bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1213\/ANE.0b013e3181d74898","article-title":"The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries","volume":"110","author":"Bateman","year":"2010","journal-title":"Anesth Analg"},{"key":"key2018010916181986_ref1-bib7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1471-0528.2011.03267.x","article-title":"Severe postpartum haemorrhage and mode of delivery: a retrospective cohort study","volume":"119","author":"Holm","year":"2012","journal-title":"BJOG"},{"key":"key2018010916181986_ref1-bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/1471-0528.13526","article-title":"WHO Statement on Caesarean Section Rates","volume":"123","author":"Betran","year":"2016","journal-title":"BJOG"},{"key":"key2018010916181986_ref1-bib9","volume-title":"NHS Maternity Statistics \u2013 England 2013\u201314","author":"Hospital Episode Statistics Analysis and Health and Social Care Information Centre","year":"2015"},{"key":"key2018010916181986_ref1-bib10","volume-title":"Scottish Confidential Audit of Severe Maternal Morbidity: Reducing Avoidable Harm","author":"Healthcare Improvement Scotland","year":"2014"},{"key":"key2018010916181986_ref1-bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/trf.13342","article-title":"Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014","volume":"56","author":"Tinegate","year":"2016","journal-title":"Transfusion"},{"key":"key2018010916181986_ref1-bib12","volume-title":"Costing Statement: Blood Transfusion. Implementing the NICE Guideline on Blood Transfusion (NG24)","author":"National Institute for Health and Care Excellence","year":"2015"},{"key":"key2018010916181986_ref1-bib13","volume-title":"Saving and Improving Lives. Strategic Plan 2015\u201320","author":"NHS Blood and Transplant","year":"2015"},{"key":"key2018010916181986_ref1-bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/trf.13529","article-title":"Patient blood management: the global view","volume":"56","author":"Shander","year":"2016","journal-title":"Transfusion"},{"key":"key2018010916181986_ref1-bib15","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1111\/trf.13260","article-title":"Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs","volume":"55","author":"Mehra","year":"2015","journal-title":"Transfusion"},{"key":"key2018010916181986_ref1-bib16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1258\/cr.2007.070009","article-title":"Intraoperative cell salvage in obstetrics","volume":"14","author":"Catling","year":"2008","journal-title":"Clinical Risk"},{"key":"key2018010916181986_ref1-bib17","volume-title":"The Annual SHOT Report 2013","author":"Bolton-Maggs","year":"2014"},{"key":"key2018010916181986_ref1-bib18","volume-title":"The 2015 Annual SHOT Report","author":"Bolton-Maggs","year":"2016"},{"key":"key2018010916181986_ref1-bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjmed.2003.12.013","article-title":"Prevalence and outcomes of anemia in surgery: a systematic review of the literature","volume":"116","author":"Shander","year":"2004","journal-title":"Am J Med"},{"key":"key2018010916181986_ref1-bib20","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1089\/jwh.2007.0605","article-title":"An assessment of medical resource utilization and hospitalization cost associated with a diagnosis of anemia in women with obstetrical bleeding in the United States","volume":"17","author":"James","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"key2018010916181986_ref1-bib21","doi-asserted-by":"publisher","first-page":"CD001888","DOI":"10.1002\/14651858.CD001888.pub3","article-title":"Cell salvage for minimising perioperative allogeneic blood transfusion","volume":"4","author":"Carless","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"44","key":"key2018010916181986_ref1-bib22","doi-asserted-by":"crossref","DOI":"10.3310\/hta10440","article-title":"Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model","volume":"10","author":"Davies","year":"2006","journal-title":"Health Technol Assess"},{"key":"key2018010916181986_ref1-bib23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2044.2009.06190.x","article-title":"Acute hypotension associated with leucocyte depletion filters during cell salvaged blood transfusion","volume":"65","author":"Sreelakshmi","year":"2010","journal-title":"Anaesthesia"},{"key":"key2018010916181986_ref1-bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2044.2010.06301.x","article-title":"Severe hypotension related to cell salvaged blood transfusion in obstetrics","volume":"65","author":"Kessack","year":"2010","journal-title":"Anaesthesia"},{"key":"key2018010916181986_ref1-bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2044.2010.06588.x","article-title":"Hypotension associated with leucocyte depletion filters following cell salvage in obstetrics","volume":"66","author":"Waldron","year":"2011","journal-title":"Anaesthesia"},{"key":"key2018010916181986_ref1-bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1075-4210(99)90002-0","article-title":"Hypotension and bedside leukocyte reduction filters","volume":"5","author":"Zoon","year":"1999","journal-title":"Int J Trauma Nurs"},{"key":"key2018010916181986_ref1-bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/bja\/aen135","article-title":"Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section","volume":"101","author":"Sullivan","year":"2008","journal-title":"Br J Anaesth"},{"key":"key2018010916181986_ref1-bib28","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00000542-200006000-00008","article-title":"Amniotic fluid removal during cell salvage in the cesarean section patient","volume":"92","author":"Waters","year":"2000","journal-title":"Anesthesiology"},{"key":"key2018010916181986_ref1-bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0002-9378(85)80153-8","article-title":"Amniotic fluid embolism: an overview and case report","volume":"152","author":"Mulder","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9378(86)90402-3","article-title":"Squamous cells in the maternal pulmonary circulation","volume":"154","author":"Clark","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9378(86)90334-0","article-title":"Squamous and trophoblastic cells in the maternal pulmonary circulation identified by invasive hemodynamic monitoring during the peripartum period","volume":"155","author":"Lee","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2007-999974","article-title":"Is amniotic fluid material in the central circulation of peripartum patients pathologic?","volume":"2","author":"Kuhlman","year":"1985","journal-title":"Am J Perinatol"},{"key":"key2018010916181986_ref1-bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tme.12299","article-title":"Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White","year":"2016","journal-title":"Transfus Med"},{"key":"key2018010916181986_ref1-bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12091","article-title":"BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn","volume":"24","author":"Qureshi","year":"2014","journal-title":"Transfus Med"},{"key":"key2018010916181986_ref1-bib35","volume-title":"The Management of Women with Red Cell Antibodies during Pregnancy","author":"Royal College of Obstetricians and Gynaecologists","year":"2014"},{"key":"key2018010916181986_ref1-bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/GCO.0000000000000116","article-title":"Does current evidence support the use of intraoperative cell salvage in reducing the need for blood transfusion in caesarean section?","volume":"26","author":"Dhariwal","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/bja\/aer168","article-title":"Intraoperative cell salvaged blood as part of a blood conservation strategy in Caesarean section: is fetal red cell contamination important?","volume":"107","author":"Ralph","year":"2011","journal-title":"Br J Anaesth"},{"key":"key2018010916181986_ref1-bib38","volume-title":"Intraoperative Blood Cell Salvage in Obstetrics","author":"National Institute for Health and Care Excellence","year":"2005"},{"key":"key2018010916181986_ref1-bib39","volume-title":"Blood Transfusion and the Anaesthetist: Intra-operative Cell Salvage","author":"Association of Anaesthetists of Great Britain and Ireland","year":"2009"},{"key":"key2018010916181986_ref1-bib40","volume-title":"Blood Transfusion in Obstetrics (Green-top Guideline No. 47)","author":"Royal College of Obstetricians and Gynaecologists","year":"2007"},{"key":"key2018010916181986_ref1-bib41","unstructured":"Teig M, Harkness M, Catling S, Clark V. Survey of Cell-salvage Use in Obstetrics in the UK. Paper presented at Annual Meeting of the Obstetric Anaesthetists Association, Sheffield, UK, 2007."},{"key":"key2018010916181986_ref1-bib42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijoa.2013.05.006","article-title":"UK survey of the availability of cell salvage and interventional radiological services for the management of obstetric haemorrhage","volume":"22","author":"Evans","year":"2013","journal-title":"Int J Obstet Anesth"},{"key":"key2018010916181986_ref1-bib43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-0528.2009.02129.x","article-title":"Cell salvage at caesarean section: the need for an evidence-based approach","volume":"116","author":"Geoghegan","year":"2009","journal-title":"BJOG"},{"key":"key2018010916181986_ref1-bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bja\/80.2.195","article-title":"Blood salvage during caesarean section","volume":"80","author":"Rainaldi","year":"1998","journal-title":"Br J Anaesth"},{"key":"key2018010916181986_ref1-bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0002-9378(98)70070-5","article-title":"The safety of intraoperative autologous blood collection and autotransfusion during cesarean section","volume":"179","author":"Rebarber","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1054\/ijoa.2001.0914","article-title":"Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre","volume":"11","author":"Catling","year":"2002","journal-title":"Int J Obstet Anesth"},{"key":"key2018010916181986_ref1-bib47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000658-198305000-00006","article-title":"Intraoperative autotransfusion. Experience in 725 consecutive cases","volume":"197","author":"Keeling","year":"1983","journal-title":"Ann Surg"},{"key":"key2018010916181986_ref1-bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1537-2995.1993.33293158054.x","article-title":"Safety and effectiveness of intracesarean blood salvage","volume":"33","author":"Jackson","year":"1993","journal-title":"Transfusion"},{"key":"key2018010916181986_ref1-bib49","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000542-199902000-00038","article-title":"Application of cell-salvage during cesarean section","volume":"90","author":"Potter","year":"1999","journal-title":"Anesthesiology"},{"key":"key2018010916181986_ref1-bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/bja\/80.4.563","article-title":"Autologous blood transfusion","volume":"80","author":"Rees","year":"1998","journal-title":"Br J Anaesth"},{"key":"key2018010916181986_ref1-bib51","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1213\/01.ANE.0000087046.91072.E8","article-title":"Intraoperative blood salvage during cesarean delivery in a patient with beta thalassemia intermedia","volume":"97","author":"Waters","year":"2003","journal-title":"Anesth Analg"},{"key":"key2018010916181986_ref1-bib52","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00006250-198812000-00030","article-title":"A simplified device for intraoperative autotransfusion","volume":"72","author":"Grimes","year":"1988","journal-title":"Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/j.1879-3479.1979.tb00461.x","article-title":"Autologous transfusion in obstetrics and gynecology","volume":"16","author":"Katz","year":"1978","journal-title":"Int J Gynaecol Obstet"},{"key":"key2018010916181986_ref1-bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9378(90)90880-G","article-title":"Autotransfusion during cesarean section","volume":"162","author":"Zichella","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijoa.2014.08.003","article-title":"Routine cell salvage during elective caesarean section: a pilot randomised trial","volume":"24","author":"Geoghegan","year":"2015","journal-title":"Int J Obstet Anesth"},{"key":"key2018010916181986_ref1-bib56","doi-asserted-by":"crossref","first-page":"e14566","DOI":"10.1371\/journal.pone.0014566","article-title":"Classifications for cesarean section: a systematic review","volume":"6","author":"Torloni","year":"2011","journal-title":"PLOS ONE"},{"key":"key2018010916181986_ref1-bib57","volume-title":"The Royal College of Anaesthetists. Classification of Urgency of Caesarean Section \u2013 A Continuum of Risk","author":"Royal College of Obstetricians and Gynaecologists","year":"2010"},{"key":"key2018010916181986_ref1-bib58","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/014107680009300703","article-title":"Urgency of caesarean section: a new classification","volume":"93","author":"Lucas","year":"2000","journal-title":"J R Soc Med"},{"key":"key2018010916181986_ref1-bib59","volume-title":"Intrapartum Care: Care of Healthy Women and their Babies During Childbirth. Clinical Guideline CG55","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"key2018010916181986_ref1-bib60","volume-title":"Intrapartum Care for Healthy Women and Babies. Clinical Guideline CG190","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"key2018010916181986_ref1-bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1423-0410.2005.00631.x","article-title":"Does washing swabs increase the efficiency of red cell recovery by cell salvage in aortic surgery?","volume":"88","author":"Haynes","year":"2005","journal-title":"Vox Sang"},{"key":"key2018010916181986_ref1-bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res"},{"key":"key2018010916181986_ref1-bib63","article-title":"Transfusion Taskforce","volume-title":"Guidelines for the Estimation of Fetomaternal Haemorrhage","author":"Working Party of the British Committee for Standards in Haematology","year":"2009"},{"key":"key2018010916181986_ref1-bib64","volume-title":"Serious Incident Framework. Supporting Learning to Prevent Recurrence","author":"NHS England Patient Safety Domain","year":"2015"},{"key":"key2018010916181986_ref1-bib65","volume-title":"Data Protection Act","author":"Great Britain","year":"1998"},{"key":"key2018010916181986_ref1-bib66","volume-title":"The Caldicott Committee. Report on the Review of Patient-Identifiable Information","author":"Department of Health","year":"1997"},{"key":"key2018010916181986_ref1-bib67","volume-title":"Research Governance Framework for Health and Social Care, Second Edition","author":"Department of Health","year":"2005"},{"key":"key2018010916181986_ref1-bib68","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1213\/01.ane.0000253232.45403.e5","article-title":"An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery","volume":"104","author":"Fong","year":"2007","journal-title":"Anesth Analg"},{"key":"key2018010916181986_ref1-bib69","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/sim.1981","article-title":"Adjusting for partially missing baseline measurements in randomized trials","volume":"24","author":"White","year":"2005","journal-title":"Stat Med"},{"key":"key2018010916181986_ref1-bib70","doi-asserted-by":"crossref","first-page":"d40","DOI":"10.1136\/bmj.d40","article-title":"Strategy for intention to treat analysis in randomised trials with missing outcome data","volume":"342","author":"White","year":"2011","journal-title":"BMJ"},{"key":"key2018010916181986_ref1-bib71","volume-title":"Prevention and Management of Postpartum Haemorrhage (Green-top Guideline No. 52)","author":"Royal College of Obstetricians and Gynaecologists","year":"2009"},{"key":"key2018010916181986_ref1-bib72","doi-asserted-by":"crossref","first-page":"e1002471","DOI":"10.1371\/journal.pmed.1002471","article-title":"Cell salvage and donor blood transfusion during cesarean section: a pragmatic, multicentre randomised controlled trial (SALVO)","volume":"14","author":"Khan","year":"2017","journal-title":"PLOS Med"},{"key":"key2018010916181986_ref1-bib73","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"key2018010916181986_ref1-bib74","volume-title":"NHS Supply Chain Catalogue 2015","author":"NHS Supply Chain"},{"key":"key2018010916181986_ref1-bib75","volume-title":"ICS Technical Factsheet 1: Swab Washing","author":"UK Cell Salvage Action Group","year":"2015"},{"key":"key2018010916181986_ref1-bib76","volume-title":"British National Formulary","author":"Joint Formulary Committee"},{"key":"key2018010916181986_ref1-bib77","volume-title":"Unit Costs of Health and Social Care 2015","author":"Curtis","year":"2015"},{"key":"key2018010916181986_ref1-bib78","volume-title":"Blood and Components Price List 2016\/2017","author":"NHS Blood and Transplant","year":"2016"},{"key":"key2018010916181986_ref1-bib79","volume-title":"NHS Reference Costs 2014\/2015","author":"Department of Health","year":"2015"},{"key":"key2018010916181986_ref1-bib80","volume-title":"2016\/17 National Prices","author":"NHS National Tariff Payment System","year":"2016"},{"key":"key2018010916181986_ref1-bib81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/bjh.12017","article-title":"Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force","volume":"159","author":"Tinegate","year":"2012","journal-title":"Br J Haematol"},{"key":"key2018010916181986_ref1-bib82","volume-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Health and Care Excellence","year":"2013"},{"key":"key2018010916181986_ref1-bib83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect Clin Res"},{"key":"key2018010916181986_ref1-bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO;2-E","article-title":"A Bayesian approach to stochastic cost-effectiveness analysis","volume":"8","author":"Briggs","year":"1999","journal-title":"Health Econ"},{"key":"key2018010916181986_ref1-bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3020","article-title":"Handling uncertainty when performing economic evaluation of healthcare interventions","volume":"3","author":"Briggs","year":"1999","journal-title":"Health Technol Assess"},{"key":"key2018010916181986_ref1-bib86","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(15)00838-7","article-title":"Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group","volume":"387","author":"Alkema","journal-title":"Lancet"},{"key":"key2018010916181986_ref1-bib87","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key2018010916181986_ref1-bib88","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/GCO.0000000000000328","article-title":"Haemorrhage at caesarean section: a framework for prevention and research","volume":"28","author":"Jardine","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key2018010916181986_ref1-bib89","volume-title":"Obtaining Valid Consent to Participate in Perinatal Research Where Consent is Time Critical","author":"Royal College of Obstetricians and Gynaecologists","year":"2016"},{"key":"key2018010916181986_ref1-bib90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijoa.2014.03.004","article-title":"Pregnant women\u2019s views on informed consent for research in labour","volume":"23","author":"George","year":"2014","journal-title":"Int J Obstet Anesth"},{"key":"key2018010916181986_ref1-bib91","doi-asserted-by":"crossref","first-page":"g2215","DOI":"10.1136\/bmj.g2215","article-title":"Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data","volume":"348","author":"Wood","year":"2014","journal-title":"BMJ"},{"key":"key2018010916181986_ref1-bib92","volume-title":"SHOT Annual Reports and Summaries","author":"SHOT","year":"2017"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta22020\/hta22020.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002773","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta22020\/hta22020.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2011935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T11:51:17Z","timestamp":1719748277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta22020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":92,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["10.3310\/hta22020"],"URL":"https:\/\/doi.org\/10.3310\/hta22020","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}